BROGI, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 4.176
EU - Europa 3.531
AS - Asia 1.701
SA - Sud America 216
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 105
OC - Oceania 6
Totale 9.873
Nazione #
US - Stati Uniti d'America 4.107
GB - Regno Unito 917
RU - Federazione Russa 692
CN - Cina 628
IT - Italia 577
SG - Singapore 479
IE - Irlanda 413
SE - Svezia 222
UA - Ucraina 194
DE - Germania 169
BR - Brasile 164
VN - Vietnam 160
FR - Francia 156
HK - Hong Kong 128
IN - India 76
FI - Finlandia 68
KR - Corea 62
ZA - Sudafrica 47
CA - Canada 40
TR - Turchia 38
BD - Bangladesh 33
AR - Argentina 24
CI - Costa d'Avorio 22
PL - Polonia 21
MX - Messico 17
ES - Italia 14
IQ - Iraq 13
BE - Belgio 12
NL - Olanda 12
AT - Austria 11
CZ - Repubblica Ceca 11
JP - Giappone 11
GR - Grecia 9
ID - Indonesia 9
MA - Marocco 9
IR - Iran 8
NG - Nigeria 7
PE - Perù 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 5
ET - Etiopia 5
JM - Giamaica 5
LT - Lituania 5
MY - Malesia 5
PK - Pakistan 5
VE - Venezuela 5
AL - Albania 4
CL - Cile 4
CO - Colombia 4
KE - Kenya 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
CH - Svizzera 3
DK - Danimarca 3
EC - Ecuador 3
EG - Egitto 3
EU - Europa 3
GE - Georgia 3
JO - Giordania 3
OM - Oman 3
PT - Portogallo 3
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
Totale 9.738
Città #
Southend 843
Fairfield 468
Dallas 440
Dublin 411
Ashburn 359
Singapore 240
Chandler 232
Woodbridge 212
Moscow 177
Beijing 176
Santa Clara 176
Wilmington 175
Cambridge 170
Seattle 166
Siena 166
Jacksonville 160
Houston 134
San Jose 132
Hong Kong 126
Milan 125
Ann Arbor 101
Hefei 74
Council Bluffs 69
Princeton 68
New York 66
Nanjing 59
Seoul 59
Dearborn 58
Rome 55
The Dalles 55
Los Angeles 52
Johannesburg 45
Ho Chi Minh City 42
Lauterbourg 41
Hanoi 38
Boardman 34
Helsinki 33
Shanghai 33
Izmir 31
Fremont 29
Bengaluru 26
San Mateo 26
San Diego 25
Munich 23
Abidjan 22
Buffalo 21
Orem 21
Florence 20
London 20
Columbus 18
Nanchang 18
Shenyang 18
Guangzhou 17
Kunming 17
Redwood City 16
São Paulo 16
Aachen 15
Washington 15
Montreal 14
Chennai 13
Brussels 12
Hebei 12
Toronto 12
Frankfurt am Main 11
Jinan 11
Norwalk 11
Warsaw 11
Brooklyn 10
Figino 10
Menlo Park 10
Boston 9
Brno 9
Changsha 9
Da Nang 9
Naples 9
Phoenix 9
Redondo Beach 9
Stockholm 9
Tianjin 9
Venezia 9
Vienna 9
Catanzaro 8
Dong Ket 8
Lappeenranta 8
Mexico City 8
Málaga 8
San Francisco 8
Tokyo 8
Turin 8
Abuja 7
Baghdad 7
Biên Hòa 7
Jiaxing 7
Lancaster 7
Ningbo 7
Tashkent 7
Bologna 6
Denver 6
Hangzhou 6
Jakarta 6
Totale 6.857
Nome #
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 411
Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II) 369
Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents 352
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA B receptor 331
Discovery of GPCR ligands for probing signal transduction pathways 326
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 322
A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents 320
Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking 309
Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies 299
Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase 289
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 288
A light in the dark: State of the art and perspectives in optogenetics and optopharmacology for restoring vision 282
Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors 276
Telomerase-based cancer therapeutics: a review on their clinical trials 272
3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors 267
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation 255
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 248
Synthesis and Antiplasmodial Activity of Bicyclic Dioxanes as Simplified Dihydroplakortin Analogues 244
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders 241
Synthetic studies toward bicyclic endoperoxides presenting polar side chains 236
Screening and phenotypical characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) inhibitors as multistage antischistosomal agents 235
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1 233
Pharmacophore Modeling for Qualitative Prediction of Antiestrogenic Activity 212
Three-Dimensional Quantitative Structure-Selectivity Relationships (3D-QSSR) Analysis Guided Rational Design of a Highly Selective Ligand for the Cannabinoid Receptor 2 206
HCV-targeted Antivirals: Current Status and Future Challenges 195
Rational design of the first difluorostatone-based PfSUB1 inhibitors 194
Dietary polyphenols rutin, taxifolin and quercetin related compounds target: Leishmania amazonensis arginase 193
Prokineticin 1 receptor agonists and their uses 187
Ionotropic Glutamate Receptor GluA2 in Complex with Bicyclic Pyrimidinedione-Based Compounds: When Small Compound Modifications Have Distinct Effects on Binding Interactions 183
Tetrahydrofuran Acetogenins from Laurencia glandulifera 165
Verbascoside Inhibits Promastigote Growth and Arginase Activity of Leishmania amazonensis 165
Development of a practical and scalable route for the preparation of the deacetoxytubuvaline (dTuv) fragment of pretubulysin and analogs 162
Pharmacophore modeling: a continuously evolving tool for computational drug design 160
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 155
Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease 136
Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents 133
Design, synthesis and biological evaluation of 7-substituted 4-phenyl-6H-imidazo[1,5-a]thieno[3,2-f] [1,4]diazepines as safe anxiolytic agents 132
The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors 130
null 109
null 101
null 100
null 99
null 90
Polypharmacology of dopamine receptor ligands 88
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 87
Plasmodium falciparum subtilisin-like protease 1: discovery of potent difluorostatone-based inhibitors 86
Totale 9.873
Categoria #
all - tutte 29.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022524 0 76 63 36 25 16 29 18 29 66 52 114
2022/2023784 44 66 106 106 91 157 22 79 69 14 21 9
2023/2024680 24 13 71 28 46 190 228 8 4 15 14 39
2024/20251.166 28 55 171 66 143 70 18 60 138 43 99 275
2025/20262.939 213 388 333 333 573 131 307 100 97 165 48 251
2026/2027144 89 55 0 0 0 0 0 0 0 0 0 0
Totale 9.873